Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yao

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature|September 9, 2021
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosisRoarke A Kamber, Yoko Nishiga, Bhek Morton, et al.
Future Oncology (London, England)|June 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCCJean-Pascal Machiels, Jérôme Fayette, Robert Haddad, et al.
Cell Metabolism|September 12, 2023
Death-seq identifies regulators of cell death and senolytic therapiesAlex Colville, Jie-Yu Liu, Cristina Rodriguez-Mateo, et al.
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.
Nature Communications|September 8, 2019
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elementsJosh Tycko, Michael Wainberg, Georgi K Marinov, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression networkAnthony M Boutelle, Aicha R Mabene, David Yao, et al.
Cell Death and Differentiation|April 22, 2025
Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression networkAnthony M Boutelle, Aicha R Mabene, David Yao, et al.
Nature Biotechnology|November 2, 2024
Development of compact transcriptional effectors using high-throughput measurements in diverse contextsJosh Tycko, Mike V Van, Aradhana, et al.
Nature|April 3, 2020
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilitiesKyuho Han, Sarah E Pierce, Amy Li, et al.
Nature Methods|March 20, 2024
Multicenter integrated analysis of noncoding CRISPRi screensDavid Yao, Josh Tycko, Jin Woo Oh, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature|September 9, 2021
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosisRoarke A Kamber, Yoko Nishiga, Bhek Morton, et al.
Future Oncology (London, England)|June 13, 2025
LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCCJean-Pascal Machiels, Jérôme Fayette, Robert Haddad, et al.
Cell Metabolism|September 12, 2023
Death-seq identifies regulators of cell death and senolytic therapiesAlex Colville, Jie-Yu Liu, Cristina Rodriguez-Mateo, et al.
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.
Nature Communications|September 8, 2019
Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elementsJosh Tycko, Michael Wainberg, Georgi K Marinov, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression networkAnthony M Boutelle, Aicha R Mabene, David Yao, et al.
Cell Death and Differentiation|April 22, 2025
Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression networkAnthony M Boutelle, Aicha R Mabene, David Yao, et al.
Nature Biotechnology|November 2, 2024
Development of compact transcriptional effectors using high-throughput measurements in diverse contextsJosh Tycko, Mike V Van, Aradhana, et al.
Nature|April 3, 2020
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilitiesKyuho Han, Sarah E Pierce, Amy Li, et al.
Nature Methods|March 20, 2024
Multicenter integrated analysis of noncoding CRISPRi screensDavid Yao, Josh Tycko, Jin Woo Oh, et al.
Pageof 5